Robert Muench

Robert Muench is a Director at Gilead Sciences, where they focus on Discovery Virology in the Hepatitis B/D Cure Program. They have previously held positions as a Senior Research Scientist and Principal Scientist II at Gilead, as well as roles at the Paul-Ehrlich-Institut and Stanford University School of Medicine, concentrating on viral vector engineering and gene therapy applications. Robert earned a PhD in Gene/Genetic Therapy from Ruprecht-Karls-Universität Heidelberg, graduating summa cum laude, and possesses extensive experience leading research teams and core facilities. Their prominent skill set includes the design and application of gene therapy vectors and the supervision of technical staff and students.